Copertina

Harnessing Chemical Diversity to Disarm Bacterial Communication for 25 Years: Natural Products, Repurposed Drugs, Peptides, and Synthetic Quorum Sensing Inhibitors

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Tung Truong‐Thanh, Anh Nguyen Phuong, Linh Nguyen Khanh, Duc Nguyen Minh
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	ChemMedChem
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Optimizing Amphipathic Antimicrobial Peptides via Helical Wheel Rotation
di: Hai Bui Thi Phuong, et al.
Pubblicazione: (2025)

Enhanced Anti‐inflammatory Effects of Diclofenac Delivered Orally via Polyvinylpyrrolidone K30/Silk Fibroin Nanoparticles in a Murine Model of Carrageenan‐Induced Paw Edema
di: Khanh Nguyen Di, et al.
Pubblicazione: (2024)

Enhancing Drug Repurposing with Consensus Docking: Discovery of Novel Discoidin Domain Receptor 1 Inhibitors
di: Jochem Nelen, et al.
Pubblicazione: (2026)

Design and Synthesis of Novel β‐Carboline‐Bisindole Hybrids as Potential Anticancer Agents
di: Nguyen Thi Thanh Huyen, et al.
Pubblicazione: (2024)

Repurposing of Inhibitors of Plasmodial Aspartate Transcarbamoylase Toward Trypanosoma Cruzi
di: Siyao Chen, et al.
Pubblicazione: (2026)

Enhancing Stability and Entrapment Efficiency of Liposome‐Coated Mesoporous Silica Nanocarriers Using Polyoxyethylene Alkyl Ether as a Polyethylene Glycol Anchoring Agent
di: Tien‐Dung Nguyen‐Dinh, et al.
Pubblicazione: (2025)

Nonsteroidal Anti‐Inflammatory Drugs as Modulators of Cation Channels: Fenamates Repurposing in Channelopathies
di: Paola Laghetti, et al.
Pubblicazione: (2025)

Curcumin Analogs Containing Pyrazole–Pyridine Hybrids as Novel Anticancer Agents: Synthesis, Cytotoxicity, Apoptosis Induction, and Molecular Modeling
di: Nam Q. H. Doan, et al.
Pubblicazione: (2025)

Hybrid Molecules as Efficient Drugs against Multidrug‐Resistant Malaria Parasites
di: Anne Robert, et al.
Pubblicazione: (2025)

Virtual and in Vitro Screening Employing a Repurposing Approach Reveal 13‐cis‐Retinoic Acid is a PTP1B Inhibitor
di: Reyna Del Carmen Navarrete‐Mondragón, et al.
Pubblicazione: (2024)

A Short Peptide Inhibitor of Measles Virus Fusion Protein that Exhibits Passive Membrane Permeability
di: Ziwei Gao, et al.
Pubblicazione: (2025)

Corrin Ring Modification in Peptide Drug Development – a Brief History of “Corrination”
di: Nancy Cham, et al.
Pubblicazione: (2025)

Exploring the Utility of Cell‐Penetrating Peptides as Vehicles for the Delivery of Distinct Antimalarial Drug Cargoes
di: Caitlin L. Gare, et al.
Pubblicazione: (2024)

Heterocycles–Containing HDAC Inhibitors Active in Cancer: An Overview of the Last Fifteen Years
di: Alessia Raucci, et al.
Pubblicazione: (2024)

Azologs of the Fatty Acid Mimetic Drug Cinalukast Enable Light‐Induced PPARα Activation
di: Minh Sai, et al.
Pubblicazione: (2024)

Nicorandil Repurposing in Orofacial Pain: Preclinical Findings in Adult Zebrafish
di: José Ismael Feitosa de Araújo, et al.
Pubblicazione: (2025)

Towards Improved Peptidic α‐Ketoamide Inhibitors of the Plasmodial Subtilisin‐Like SUB1: Exploration of N‐Terminal Extensions and Cyclic Constraints
di: Anna K. Puszko, et al.
Pubblicazione: (2025)

Front Cover: Corrin Ring Modification in Peptide Drug Development – a Brief History of “Corrination” (ChemMedChem 10/2025)
di: Nancy Cham, et al.
Pubblicazione: (2025)

AMPK Activation by 2′‐Hydroxy‐2,4,5‐Trimethoxychalcone Derivatives in Podocyte Cells
di: Vu‐Duy Nguyen, et al.
Pubblicazione: (2025)

Front Cover: Structure‐Based Drug Design of Novel Heterocyclic Scaffolds as TgCDPK1 Inhibitors (ChemMedChem 18/2025)
di: Anoopjit Singh Kooner, et al.
Pubblicazione: (2025)

Targeting N‐Methyl‐lysine Histone Demethylase KDM4 in Cancer: Natural Products Inhibitors as a Driving Force for Epigenetic Drug Discovery
di: Ilaria Cursaro, et al.
Pubblicazione: (2024)

Small Molecule‐Drug Conjugates: Opportunities for the Development of Targeted Anticancer Drugs
di: Jingjing Zhang, et al.
Pubblicazione: (2024)

APH Inhibitors that Reverse Aminoglycoside Resistance in Enterococcus casseliflavus
di: Elise Kaplan, et al.
Pubblicazione: (2025)

The Role of Protein Disulfide Isomerase Inhibitors in Cancer Therapy
di: Qiuying Nie, et al.
Pubblicazione: (2024)

Challenges for the Discovery of Non‐Covalent WRN Helicase Inhibitors
di: Alisa Heuser, et al.
Pubblicazione: (2024)

Advanced Hydrogels: Enhancing Tissue Bioengineering with RGD Peptides and Carbon Nanomaterials
di: Josué M. Galindo, et al.
Pubblicazione: (2024)

Design and Evaluation of Tyrosine‐Rich Antimicrobial Peptides With Quadruple Repeating Units
di: Heiya Na, et al.
Pubblicazione: (2026)

Pantinin‐Derived Peptides against Veterinary Herpesviruses: Activity and Structural Characterization
di: Rosa Giugliano, et al.
Pubblicazione: (2025)

Small‐Molecule KRAS Inhibitors by Tyrosine Covalent Bond Formation
di: Alexander D. Landgraf, et al.
Pubblicazione: (2025)

Binding‐Site Switch for Protein Kinase CK2 Inhibitors
di: Dylan Grenier, et al.
Pubblicazione: (2025)

Decoding Urease Inhibition: A Comprehensive Review of Inhibitor Scaffolds
di: Nuno Martinho, et al.
Pubblicazione: (2026)

Thiazole‐Based IL‐17 Inhibitors Discovered by Scaffold Morphing
di: Juraj Velcicky, et al.
Pubblicazione: (2025)

Gram‐Scale Synthesis of an Arylsulfonamide‐Type Alkaline Phosphatase Inhibitor
di: Zsolt Rapi, et al.
Pubblicazione: (2026)

Biaryl Phosphate‐Based Inhibitors of the Transcription Factor STAT4
di: Nadiya Brovchenko, et al.
Pubblicazione: (2025)

Balinatunfib: A Clinical Oral Small Molecule TNFα Inhibitor
di: Alexander Dömling, et al.
Pubblicazione: (2025)

2‐Carboxyquinoline Boronic Acids as Highly Potent KPC Inhibitors
di: Zheng Ma, et al.
Pubblicazione: (2025)

Development of New Peptidomimetic NADPH Oxidase Inhibitors with Antithrombotic Properties
di: Elisabetta Scalia, et al.
Pubblicazione: (2024)

Structure‐Atropisomer Stability Relationship in Selective MCL‐1 Inhibitors
di: Szabolcs Sipos, et al.
Pubblicazione: (2025)

From Deep Learning to the Discovery of Promising VEGFR‐2 Inhibitors
di: Mehmet Ali Yucel, et al.
Pubblicazione: (2024)

Flavonoid‐Quinoxaline Hybrid Compounds as Cathepsin Inhibitors Against Fascioliasis
di: Florencia Ferraro, et al.
Pubblicazione: (2024)